Fig. 1
From: Calretinin as a blood-based biomarker for mesothelioma
Marker concentrations in MM subtypes. a Calretinin [ng/mL] in controls and MM cases by subtype. b Mesothelin [nmol/L] in controls and MM cases by subtype. All cases and controls were from Australia (group 1). Individual p-values relate to the comparison between each subtype and the controls. P-values for calretinin were obtained from two-sided Peto-Prentice test and for mesothelin from two-sided Wilcoxon rank-sum test